The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Genetic susceptibility to breast cancer
Open accessAbstract
Genetic and lifestyle/environmental factors are implicated in the aetiology of breast cancer. This review summarizes the current state of knowledge on rare high penetrance mutations, as well as moderate and low‐penetrance genetic variants implicated in breast cancer aetiology. We summarize recent discoveries from large collaborative efforts to combine data from candidate gene studies, and to conduct genome‐wide association studies (GWAS), primarily in breast cancers in the general population. These findings are compared with results from collaborative efforts aiming to identify genetic modifiers in BRCA1 and BRCA2 carriers. Breast cancer is a heterogeneous disease, and tumours from BRCA1 and BRCA2 carriers display distinct pathological characteristics when compared with tumours unselected for family history. The relationship between genetic variants and pathological subtypes of breast cancer, and the implication of discoveries of novel genetic variants to risk prediction in BRCA1/2 mutation carriers and in populations unselected for mutation carrier status, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Self-citationLinkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Self-citationBreast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Self-citationWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Self-citationPeutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
Jenne, D. E., Reomann, H., Nezu, J.-I., Friedel, W., Loff., S., Jeschke, R., Müller, O., Back, W., & Zimmer, M. (1998) · Nature Genetics · doi:10.1038/ng0198-38 · Cited by 1,205
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171 · cited 1×
“…may be offered more personalized clin- ical management and receive prophylactic therapies such as oophorectomy or mastectomy; or aromatase inhibitors, in the case of ER-positive disease (Friebel et al., 2007; Hartmann et al., 2001; Meijers-Heijboer et al., 2001; Rebbeck et al., 2002, 2004, 2009b).”
BackgroundBiallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · cited 1×
“Bi-allelic germ-line mutations in BRCA2 are associated with a subgroup of Fanconi anaemia (D1) in which there is susceptibility to childhood tu- mors (Howlett et al., 2002).”
BackgroundThe CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Self-citationBreast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973 · cited 1×
“…may be offered more personalized clin- ical management and receive prophylactic therapies such as oophorectomy or mastectomy; or aromatase inhibitors, in the case of ER-positive disease (Friebel et al., 2007; Hartmann et al., 2001; Meijers-Heijboer et al., 2001; Rebbeck et al., 2002, 2004, 2009b).”
BackgroundRebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Polygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Self-citationLakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Self-citationStacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Self-citationEfficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Self-citationLakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Self-citationLocalization of the gene for Cowden disease to chromosome 10q22–23
Nelen, M. R., Padberg, G. W., Peeters, E. A. J., Lin, A. Y., Helm, B. V. D., Frants, R. R., Goulon, V., Goldstein, A. M., Reen, M. M. M. V., Eastern, D. F., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-114 · Cited by 668
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer
Pharoah, P. D. P., Antoniou, A. C., Easton, D. F., & Ponder, B. A. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0708739 · Cited by 618
Self-citationA common coding variant in CASP8 is associated with breast cancer risk
The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Cox, A., on behalf of the Breast Cancer Association Consortium, Dunning, A. M., Garcia-Closas, M., Balasubramanian, S., Reed, M. W. R., Pooley, K. A., Scollen, S., Baynes, C., et al. (2007) · Nature Genetics · doi:10.1038/ng1981 · Cited by 610
Self-citationKauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., Isaacs, C., Evans, D. G., Lynch, H., Eeles, R. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9626 · Cited by 589
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Stratton, M. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10109-4 · Cited by 579
Histological types of breast cancer: How special are they?
Weigelt, B., Geyer, F. C., & Reis-Filho, J. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.004 · Cited by 572
Parental origin of sequence variants associated with complex diseases
DIAGRAM Consortium, Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., Jonasdottir, A., Sigurdsson, A., Kristinsson, K. T., et al. (2009) · Nature · doi:10.1038/nature08625 · Cited by 553
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Zheng, W., Long, J., Gao, Y.-T., Li, C., Zheng, Y., Xiang, Y.-B., Wen, W., Levy, S., Deming, S. L., Haines, J. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.318 · Cited by 541
Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., & Bartel, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31941 · Cited by 539
Thomas, G., Jacobs, K. B., Kraft, P., Yeager, M., Wacholder, S., Cox, D. G., Hankinson, S. E., Hutchinson, A., Wang, Z., Yu, K., et al. (2009) · Nature Genetics · doi:10.1038/ng.353 · Cited by 536
Self-citationRisk Factors for Breast Cancer According to Estrogen and Progesterone Receptor Status
Colditz, G. A., Rosner, B. A., Chen, W. Y., Holmes, M. D., & Hankinson, S. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh025 · Cited by 533
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Self-citationA comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citationNewly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
SEARCH, Ahmed, S., The GENICA Consortium, kConFab, Australian Ovarian Cancer Study Group, Thomas, G., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., et al. (2009) · Nature Genetics · doi:10.1038/ng.354 · Cited by 477
Self-citation(2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 471
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
Antoniou, A. C., Pharoah, P. P. D., Smith, P., & Easton, D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602175 · Cited by 467
Self-citationRelative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer
Stacey, S. N., Manolescu, A., Sulem, P., Thorlacius, S., Gudjonsson, S. A., Jonsson, G. F., Jakobsdottir, M., Bergthorsson, J. T., Gudmundsson, J., Aben, K. K., et al. (2008) · Nature Genetics · doi:10.1038/ng.131 · Cited by 459
Medullary carcinoma of the breast.A clinicopathologic study with 10 year follow-up
Ridolfi, R. L., Rosen, P. P., Port, A., Kinne, D., & Miké, V. (1977) · Cancer · doi:10.1002/1097-0142(197710)40:4<1365::aid-cncr2820400402>3.0.co;2-n · Cited by 424
Performance of Common Genetic Variants in Breast-Cancer Risk Models
Wacholder, S., Hartge, P., Prentice, R., Garcia-Closas, M., Feigelson, H. S., Diver, W. R., Thun, M. J., Cox, D. G., Hankinson, S. E., Kraft, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907727 · Cited by 411
Self-citationVariants in DNA double-strand break repair genes and breast cancer susceptibility
Kuschel, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1399 · Cited by 387
Garcia-Closas, M., Hall, P., Nevanlinna, H., Pooley, K., Morrison, J., Richesson, D. A., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Arias, J. I., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000054 · Cited by 378
Self-citationTumour biological features of BRCA1-induced breast and ovarian cancer
Jóhannsson, Ó. T., Idvall, I., Anderson, C., Borg, Å., Barkardóttir, R. B., Egilsson, V., & Olsson, H. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)89007-7 · Cited by 345
Genes Associated With Breast Cancer Metastatic to Bone
Smid, M., Wang, Y., Klijn, J. G. M., Sieuwerts, A. M., Zhang, Y., Atkins, D., Martens, J. W. M., & Foekens, J. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8802 · Cited by 314
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Study, A. C. (., Song, H., The Australian Ovarian Cancer Study Group, The Ovarian Cancer Association Consortium, Ramus, S. J., Tyrer, J., Bolton, K. L., Gentry-Maharaj, A., Wozniak, E., Anton-Culver, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.424 · Cited by 313
Self-citationGenetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
Easton, D., Bishop, D., Ford, D., Crockford, G., Haites, N., Milner, B. J., Allan, L., King, M., Bowcock, A. M., Anderson, L., et al. (1993) · UCL Discovery (University College London) · Cited by 309
Self-citationModels of genetic susceptibility to breast cancer
Antoniou, A. C., & Easton, D. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209879 · Cited by 303
Self-citationGenetic Predisposition to Breast Cancer: Past, Present, and Future
Turnbull, C., & Rahman, N. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164339 · Cited by 302
High constant incidence in twins and other relatives of women with breast cancer
Peto, J., & Mack, T. M. (2000) · Nature Genetics · doi:10.1038/82533 · Cited by 301
Triple‐negative breast cancer: Present challenges and new perspectives
Podo, F., Buydens, L. M. C., Degani, H., Hilhorst, R., Klipp, E., Gribbestad, I. S., Van Huffel, S., W.M. van Laarhoven, H., Luts, J., Monleon, D., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.006 · Cited by 299
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33
Gold, B., Kirchhoff, T., Stefanov, S., Lautenberger, J., Viale, A., Garber, J., Friedman, E., Narod, S., Olshen, A. B., Gregersen, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800441105 · Cited by 297
Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast Cancer
Foulkes, W. D., Metcalfe, K., Sun, P., Hanna, W. M., Lynch, H. T., Ghadirian, P., Tung, N., Olopade, O. I., Weber, B. L., McLennan, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-1061 · Cited by 293
Antoniou, A. C., Spurdle, A. B., Sinilnikova, O. M., Healey, S., Pooley, K. A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.02.008 · Cited by 283
Self-citationAllele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
Meyer, K. B., Maia, A.-T., O'Reilly, M., Teschendorff, A. E., Chin, S.-F., Caldas, C., & Ponder, B. A. J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060108 · Cited by 280
Variation of Breast Cancer Risk Among BRCA1/2 Carriers
Begg, C. B., Haile, R. W., Borg, Å., Malone, K. E., Concannon, P., Thomas, D. C., Langholz, B., Bernstein, L., Olsen, J. H., Lynch, C. F., et al. (2008) · JAMA · doi:10.1001/jama.2007.55-a · Cited by 279
Huang, W.-Y., Newman, B., Millikan, R. C., Schell, M. J., Hulka, B. S., & Moorman, P. G. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010265 · Cited by 278
Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family
Amundadottir, L. T., Thorvaldsson, S., Gudbjartsson, D. F., Sulem, P., Kristjansson, K., Arnason, S., Gulcher, J. R., Bjornsson, J., Kong, A., Thorsteinsdottir, U., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010065 · Cited by 270
Sun, T., Gao, Y., Tan, W., Ma, S., Shi, Y., Yao, J., Guo, Y., Yang, M., Zhang, X., Zhang, Q., et al. (2007) · Nature Genetics · doi:10.1038/ng2030 · Cited by 269
Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. S., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Venter, D. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n · Cited by 259
Prediction and Interaction in Complex Disease Genetics: Experience in Type 1 Diabetes
Clayton, D. G. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000540 · Cited by 258
The Breast Cancer Association Consortium (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj374 · Cited by 258
The Genetic Epidemiology of Breast Cancer Genes
Thompson, D., & Easton, D. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048770.90334.3b · Cited by 257
Self-citationPathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., McGuffog, L., Steele, D., Devilee, P., Klijn, J. G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1029-3 · Cited by 252
Self-citationPotter, J. D., Cerhan, J. R., Sellers, T. A., McGovern, P. G., Drinkard, C. R., Kushi, L. H., & Folsom, A. R. (1995) · PubMed · Cited by 248
The Small Subunit of the Mammalian Mitochondrial Ribosome
Cavdar Koc, E., Burkhart, W., Blackburn, K., Moseley, A., & Spremulli, L. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100727200 · Cited by 245
Genome-wide association studies in cancer
Easton, D. F., & Eeles, R. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn287 · Cited by 243
Self-citationAntoniou, A. C., Sinilnikova, O. M., Simard, J., Léoné, M., Dumont, M., Neuhausen, S. L., Struewing, J. P., Stoppa-Lyonnet, D., Barjhoux, L., Hughes, D. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522611 · Cited by 241
Self-citationAdnane, J., Gaudray, P., Ca, D., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., & Theillet, C. G. (1991) · PubMed · Cited by 240
Armes, J. E., Trute, L., White, D., Southey, M. C., Hammet, F., Tesoriero, A. A., Hutchins, A., Dite, G. S., McCredie, M. R. E., Giles, G. G., et al. (1999) · PubMed · Cited by 236
Andrieu, N., Goldgar, D. E., Easton, D. F., Rookus, M., Brohet, R., Antoniou, A. C., Peock, S., Evans, G., Eccles, D., Douglas, F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj132 · Cited by 231
Self-citationLakhani, S. R., Gusterson, B. A., Jacquemier, J. D., Sloane, J. P., Anderson, T. J., van de Vijver, M. J., Venter, D. J., Freeman, A., Antoniou, A., McGuffog, L., et al. (2000) · PubMed · Cited by 222
Self-citationBRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen, J. J., Silver, D. P., Cantor, S., Livingston, D. M., & Scully, R. (1999) · PubMed · Cited by 217
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
Begg, C. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1221 · Cited by 201
Methodological challenges of genome-wide association analysis in Africa
Teo, Y.-Y., Small, K. S., & Kwiatkowski, D. P. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2731 · Cited by 195
Caspase-8 in cancer biology and therapy
Fulda, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.023 · Cited by 193
Germline E-cadherin mutations in familial lobular breast cancer
Masciari, S., Larsson, N., Senz, J., Boyd, N., Kaurah, P., Kandel, M. J., Harris, L. N., Pinheiro, H. C., Troussard, A., Miron, P., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051268 · Cited by 190
Variation in BRCA1 cancer risks by mutation position.
Thompson, D. J., & Easton, D. F. (2002) · PubMed · Cited by 187
Self-citationBreast Cancer in African-American Women: Differences in Tumor Biology from European-American Women
Amend, K., Hicks, D., & Ambrosone, C. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1927 · Cited by 187
Loman, N., Johannsson, O., Bendahl, P.-O., Borg, �., Fern�, M., & Olsson, H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980715)83:2<310::aid-cncr15>3.0.co;2-w · Cited by 184
Modifiers of risk of hereditary breast and ovarian cancer
Narod, S. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc726 · Cited by 179
Genomic instability in breast cancer: Pathogenesis and clinical implications
Kwei, K. A., Kung, Y., Salari, K., Holcomb, I. N., & Pollack, J. R. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.001 · Cited by 179
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers
Cullinane, C. A., Lubinski, J., Neuhausen, S. L., Ghadirian, P., Lynch, H. T., Isaacs, C., Weber, B., Moller, P., Offit, K., Kim‐Sing, C., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21273 · Cited by 176
Palacios, J., Honrado, E., Osório, A., Cazorla, A., Sarrió, D., Barroso, A., Rodríguez, S., Cigudosa, J. C., Dı́ez, O., Alonso, C., et al. (2003) · PubMed · Cited by 175
Luqmani, Y., Graham, M., & Coombes, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.256 · Cited by 165
Bartkova, J., Tommiska, J., Oplustilova, L., Aaltonen, K., Tamminen, A., Heikkinen, T., Mistrik, M., Aittomäki, K., Blomqvist, C., Heikkilä, P., et al. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.09.007 · Cited by 158
Heikkinen, T., Kärkkäinen, H., Aaltonen, K., Milne, R. L., Heikkilä, P., Aittomäki, K., BLOMQVIST, C. P., & Nevanlinna, H. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3128 · Cited by 158
Navin, N. E., & Hicks, J. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.010 · Cited by 152
TOX defines a conserved subfamily of HMG-box proteins
O'Flaherty, E., & Kaye, J. (2003) · BMC Genomics · doi:10.1186/1471-2164-4-13 · Cited by 148
Established breast cancer risk factors by clinically important tumour characteristics
García‐Closas, M., Brinton, L. A., Lissowska, J., Chatterjee, N., Pepłońska, B., Anderson, W. F., Szeszenia‐Dąbrowska, N., Bardin‐Mikolajczak, A., Zatoński, W. A., Blair, A. E., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603207 · Cited by 145
Deconstructing the molecular portrait of basal-like breast cancer
Yehiely, F., Moyano, J. V., Evans, J. R., Nielsen, T. O., & Cryns, V. L. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.004 · Cited by 144
Cotterchio, M., Kreiger, N., Theis, B., Sloan, M., & Bahl, S. (2003) · PubMed · Cited by 141
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status
García‐Closas, M., & Chanock, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0975 · Cited by 141
Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development
Chen, Y., Choong, L., Lin, Q., Philps, R., Wong, C., Ang, B. K., Tan, Y.-L., Loh, M. C. S., Hew, C.-L., Shah, N., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700395-mcp200 · Cited by 139
A new face on apoptosis: death‐associated protein 3 and PDCD9 are mitochondrial ribosomal proteins
Koc, E. C., Ranasinghe, A., Burkhart, W., Blackburn, K., Koç, H., Moseley, M. A., & Spremulli, L. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02250-5 · Cited by 135
Value of Adding Single-Nucleotide Polymorphism Genotypes to a Breast Cancer Risk Model
Gail, M. H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp130 · Cited by 131
Udler, M. S., Meyer, K. B., Pooley, K. A., Karlins, E., Struewing, J. P., Zhang, J., Doody, D. R., MacArthur, S., Tyrer, J. P., Pharoah, P. D. P., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp078 · Cited by 127
Self-citationOsório, A., de la Hoya, M., Rodríguez‐López, R., Martínez‐Ramírez, Á., Cazorla, A., Granizo, J. J., Esteller, M., Rivas, C., Caldés, T., & Benitez, J. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10337 · Cited by 125
Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women
Rosenberg, L., Einarsdóttir, K., Isaksson-Friman, E., Wedrén, S., Dickman, P. W., Hall, P. N., & Magnusson, C. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0489 · Cited by 124
The death effector domain protein family
Barnhart, B. C., Lee, J. C., Alappat, E. C., & Peter, M. E. (2003) · Oncogene · doi:10.1038/sj.onc.1207103 · Cited by 120
Hopper, J. L., & Carlin, J. B. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116580 · Cited by 119
Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival
Joslyn, S. A. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015220420400 · Cited by 114
Moffa, A. B., Tannheimer, S. L., & Ethier, S. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.643.2.11 · Cited by 114
Breast Cancer Heterogeneity: A Mixture of At Least Two Main Types?
Anderson, W. F., & Matsuno, R. K. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj295 · Cited by 111
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antoniou, A. C., Sinilnikova, O. M., McGuffog, L., Healey, S. C., Nevanlinna, H. A., Heikkinen, T., Simard, J., Spurdle, A. B., Beesley, J., Chen, X., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp372 · Cited by 111
Self-citationMilne, R. L., Benitez, J. J., Nevanlinna, H. A., Heikkinen, T., Aittomäki, K., BLOMQVIST, C. P., Arias, J. I., Zamora, M. P., Burwinkel, B., Bartram, C. R., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp167 · Cited by 105
Self-citationChu, K. C., & Anderson, W. F. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016361932220 · Cited by 95
Friebel, T. M., Domchek, S. M., Neuhausen, S. L., Wagner, T. M., Evans, D. G., Isaacs, C. J., Garber, J. E., Daly, M. B., Eeles, R. A., Matloff, E. T., et al. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.053 · Cited by 93
Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors
Dickson, C., Spencer‐Dene, B., Dillon, C., & Fantl, V. (2000) · Breast Cancer Research · doi:10.1186/bcr53 · Cited by 90
Familial risks of breast cancer
Easton, D. F. (2002) · Breast Cancer Research · doi:10.1186/bcr448 · Cited by 85
Self-citationEvaluation of 11 Breast Cancer Susceptibility Loci in African-American Women
Zheng, W., Cai, Q., Signorello, L. B., Long, J., Hargreaves, M. K., Deming, S. L., Li, G., Li, C., Cui, Y., & Blot, W. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0624 · Cited by 83
Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer
Webb, P. M., Hopper, J. L., Newman, B. M., Chen, X., Kelemen, L., Giles, G. G., Southey, M. C., Chenevix‐Trench, G., & Spurdle, A. B. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0335 · Cited by 82
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Milne, R. L., Osório, A., y Cajal, T. R., Baiget, M., Lasa, A., Díaz‐Rubio, E., de la Hoya, M., Caldés, T., Teulé, À., Lázaro, C., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0394-1 · Cited by 76
The pathology of familial breast cancer: Immunohistochemistry and molecular analysis
Osin, P. P., & Lakhani, S. R. (1999) · Breast Cancer Research · doi:10.1186/bcr11 · Cited by 69
Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.
Phillips, K. (2000) · PubMed · Cited by 66
Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention
Cybulski, C., Huzarski, T., Byrski, T., Gronwald, J., Dębniak, T., Jakubowska, A., Górski, B., Wokołorczyk, D., Masojć, B., Narod, S., et al. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01111.x · Cited by 64
Yang, X. R., Pfeiffer, R. M., García‐Closas, M., Rimm, D. L., Lissowska, J., Brinton, L. A., Pepłońska, B., Hewitt, S. M., Cartun, R. W., Mandich, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2142 · Cited by 62
Common Genetic Variation in Candidate Genes and Susceptibility to Subtypes of Breast Cancer
Mavaddat, N., Dunning, A. M., Ponder, B. A. J., Easton, D. F., & Pharoah, P. D. P. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0704 · Cited by 61
Self-citationGERMLINE p53 MUTATIONS AND HERITABLE CANCER
Malkin, D. (1994) · Annual Review of Genetics · doi:10.1146/annurev.ge.28.120194.002303 · Cited by 59
Polygenic Susceptibility to Breast Cancer: Current State-of-The-Art
Ghoussaini, M., & Pharoah, P. D. P. (2009) · Future Oncology · doi:10.2217/fon.09.29 · Cited by 58
Familial predisposition to breast cancer in a British population
Pharoah, P. D. P., Lipscombe, J. M., Redman, K., Day, N. E., Easton, D. F., & Ponder, B. A. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00023-x · Cited by 55
Self-citationThe CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Frank, B., Rigas, S. H., Bermejo, J. L., Wiestler, M., Wagner, K., Hemminki, K., Reed, M., Sutter, C., Wappenschmidt, B., Balasubramanian, S. P., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9752-z · Cited by 54
Self-citationNovel indications forBRCA1 screening using individual clinical and morphological features
Eisinger, F., Noguès, C., Guinebreti�re, J.-M., Peyrat, J., Bardou, V.-J., Noguchi, T., Vennin, P., Sauvan, R., Lidereau, R., Birnbaum, D., et al. (1999) · International Journal of Cancer · Cited by 54
Sherman, M. E., Rimm, D. L., Yang, X. R., Chatterjee, N., Brinton, L. A., Lissowska, J., Pepłońska, B., Szeszenia‐Dąbrowska, N., Zatoński, W. A., Cartun, R. W., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22812 · Cited by 50
An Admixture Scan in 1,484 African American Women with Breast Cancer
Fejerman, L., Haiman, C. A., Reich, D., Tandon, A., Deo, R. C., John, E. M., Ingles, S. A., Ambrosone, C. B., Bovbjerg, D. H., Jandorf, L. H., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0464 · Cited by 49
Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status
Rusiecki, J. A., Holford, T. R., Zahm, S. H., & Zheng, T. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.07.004 · Cited by 46
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Mavaddat, N., Pharoah, P. D. P., Blows, F. M., Driver, K. E., Provenzano, E., Thompson, D. J., MacInnis, R. J., Shah, M., The SEARCH Team, Easton, D. F., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2476 · Cited by 45
Self-citationKeratinocyte growth factor-induced motility of breast cancer cells
Zang, X. P., & Pento, J. T. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011997317994 · Cited by 42
Molecular basis for therapy resistance
Lønning, P. E. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.005 · Cited by 41
Hishikawa, Y., Tamaru, N., 江島, 邦., Hayashi, T., & Koji, T. (2004) · Archivum histologicum japonicum · doi:10.1679/aohc.67.455 · Cited by 38
Comparison between genotype and phenotype identifies a high-risk population carryingBRCA1 mutations
Cortesi, L., Turchetti, D., Bertoni, C., Bellei, R., Mangone, L., Vinceti, M., Federico, M., Silingardi, V., & Ferrari, S. (2000) · Genes Chromosomes and Cancer · Cited by 34
Ruiz-Narváez, E., Rosenberg, L. A., Rotimi, C. N., Cupples, L. A., Boggs, D. A., Adeyemo, A., Cozier, Y. C., Adams-Campbell, L. L., & Palmer, J. R. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0775-5 · Cited by 29
Welsh, M. L., Buist, D. S. M., Bowles, E. J. A., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0026-1 · Cited by 26
The 6q22.33 Locus and Breast Cancer Susceptibility
Kirchhoff, T., Chen, Z.-Q., Gold, B., Pal, P., Gaudet, M. M., Kosarin, K., Levine, D. A., Gregersen, P. K., Spencer, S., Harlan, M., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0151 · Cited by 26
kConFab, Sinilnikova, O. M., OCGN, HEBON, EMBRACE, GEMO, GC-HBOC, Antoniou, A. C., Simard, J., Healey, S. C., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605279 · Cited by 26
Self-citationAssociation between the CHEK2*1100delC germ line mutation and estrogen receptor status
de Bock, G. H., Mourits, M. J. E., Schutte, M. E. M., Krol-Warmerdam, E. M., Seynaeve, C., Blom, J., Brekelmans, C. T. M., Meijers-Heijboer, H. E. J., van Asperen, C. J., Cornelisse, C. J., et al. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00694.x · Cited by 22
Zhang, Y., Sugimoto, Y., Kulp, S. K., et al. (1998) · Oncology Reports · doi:10.3892/or.5.3.577 · Cited by 19
Cited by
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Self-citationPrediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Mavaddat, N., Pharoah, P. D. P., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., Wang, Q., Dennis, J., Dunning, A. M., Shah, M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv036 · Cited by 550
Self-citationMicronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies
Bonassi, S., El-Zein, R., Bolognesi, C., & Fenech, M. (2011) · Mutagenesis · doi:10.1093/mutage/geq075 · Cited by 471
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
The Gene ENvironmental Interaction and breast CAncer (GENICA) Network, Garcia-Closas, M., kConFab Investigators, (FBCS), F. B. C. S., Australian Breast Cancer Tissue Bank (ABCTB) Investigators, Couch, F. J., Lindstrom, S., Michailidou, K., Schmidt, M. K., Brook, M. N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2561 · Cited by 406
Self-citationPersonalized Medicine: Progress and Promise
Chan, I. S., & Ginsburg, G. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101446 · Cited by 399
Metadata
- Authors
- Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia-Closas, M.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2010-05-21
- Volume
- 4
- Issue
- 3
- Pages
- 174-191
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2083697259
- Cited by
- 375
- References
- 155
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.